标题
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 27, Issue 5, Pages 475-489
出版商
Informa UK Limited
发表日期
2018-05-04
DOI
10.1080/13543784.2018.1471132
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
- (2017) Amelia L. Parker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- Orlistat treatment induces apoptosis and arrests cell cycle in HSC-3 oral cancer cells
- (2017) Xia Xiao et al. MICROBIAL PATHOGENESIS
- Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells
- (2017) Joshua J. Souchek et al. MOLECULAR CANCER THERAPEUTICS
- Dosing Three‐Drug Combinations That Include Targeted Anti‐Cancer Agents: Analysis of 37,763 Patients
- (2017) Mina Nikanjam et al. ONCOLOGIST
- FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression
- (2017) Timothy S. Heuer et al. EBioMedicine
- A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer
- (2017) Dana B. Cardin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Discontinuation of TKI therapy and ‘functional’ cure for CML
- (2016) François-Xavier Mahon BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells
- (2016) Jan Baumann et al. BMC CANCER
- Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer
- (2016) Mahesh C. Sharma et al. CANCER LETTERS
- Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors
- (2016) Thelma S. Angeles et al. Expert Opinion on Drug Discovery
- Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression
- (2016) Kaiyan Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome
- (2016) Aparna Prasad et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Conundrum of Genetic “Drivers” in Benign Conditions
- (2016) Shumei Kato et al. JNCI-Journal of the National Cancer Institute
- Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
- (2016) JIANGMAN DUAN et al. Molecular Medicine Reports
- Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines
- (2016) Tanner K. Hill et al. MOLECULAR PHARMACEUTICS
- Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines
- (2016) Weiya Z. Wysham et al. Targeted Oncology
- Dosing de novo combinations of two targeted drugs: Towards a customized precision medicine approach to advanced cancers
- (2016) Sariah Liu et al. Oncotarget
- Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
- (2016) Byungho Lim et al. Oncotarget
- P300 acetyltransferase regulates fatty acid synthase expression, lipid metabolism and prostate cancer growth
- (2016) Xiaokun Gang et al. Oncotarget
- The Conundrum of Genetic “Drivers” in Benign Conditions
- (2016) Shumei Kato et al. JNCI-Journal of the National Cancer Institute
- Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells
- (2015) Daniel I. Benjamin et al. ACS Chemical Biology
- Tumor suppressor p53 and its mutants in cancer metabolism
- (2015) Juan Liu et al. CANCER LETTERS
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
- (2015) Amrita Khwairakpam et al. CURRENT DRUG TARGETS
- A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways
- (2015) Ana P Gomes et al. CURRENT OPINION IN BIOTECHNOLOGY
- Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma
- (2015) T. Shirota et al. MOLECULAR CANCER THERAPEUTICS
- Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
- (2015) R. Paulmurugan et al. MOLECULAR CANCER THERAPEUTICS
- The expanding role of mTOR in cancer cell growth and proliferation
- (2015) Marie Cargnello et al. MUTAGENESIS
- Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids
- (2015) DIANA CERVANTES-MADRID et al. ONCOLOGY REPORTS
- Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy
- (2015) J Cheng et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Energy Metabolism in a Matched Model of Radiation Resistance for Head and Neck Squamous Cell Cancer
- (2015) Jade Mims et al. RADIATION RESEARCH
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- Personalized treatments of cancer patients: A reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
- (2014) Monica Arnedos et al. CANCER TREATMENT REVIEWS
- Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
- (2014) Nor Eddine Sounni et al. Cell Metabolism
- A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
- (2014) Komal Jhaveri et al. Clinical Breast Cancer
- Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer Development
- (2014) Chi-Yun Wang et al. DISEASE MARKERS
- Prognostic Impact of Fatty Acid Synthase Expression in Upper Urinary Tract Urothelial Carcinoma
- (2014) Shinsuke Hamada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis
- (2014) Susanne Grube et al. JOURNAL OF NEURO-ONCOLOGY
- A Cancer Theory Kerfuffle Can Lead to New Lines of Research
- (2014) S. G. Baker JNCI-Journal of the National Cancer Institute
- Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
- (2014) Yunlang Cai et al. MEDICAL ONCOLOGY
- Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications
- (2014) Wei Wang et al. MEDICINAL RESEARCH REVIEWS
- Plk1 Phosphorylation of PTEN Causes a Tumor-Promoting Metabolic State
- (2014) Z. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death
- (2014) C-S Yang et al. ONCOGENE
- Fatty acid synthase (FASN) levels in serum of colorectal cancer patients: correlation with clinical outcomes
- (2014) Qi-qiang Long et al. TUMOR BIOLOGY
- Elevated levels of serum fatty acid synthase in patients with gastric carcinoma
- (2014) TOMOAKI ITO et al. Oncology Letters
- A growing role for mTOR in promoting anabolic metabolism
- (2013) Jessica J. Howell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors
- (2013) Suryanarayanan Vandhana et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids
- (2013) Sharon M. Louie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas
- (2013) M. Agostini et al. MOLECULAR CANCER THERAPEUTICS
- Signal integration by mTORC1 coordinates nutrient input with biosynthetic output
- (2013) Christian C. Dibble et al. NATURE CELL BIOLOGY
- Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome
- (2013) Yukie Yoshii et al. PLoS One
- High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer
- (2013) Jiahong Wang et al. PLoS One
- Metabolic sensors and their interplay with cell signalling and transcription
- (2012) Alena Krejčí BIOCHEMICAL SOCIETY TRANSACTIONS
- Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: Role of cell survival regulatory molecules
- (2012) Shiva Kant et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells
- (2012) Jin-Qiang Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas
- (2012) F Seguin et al. BRITISH JOURNAL OF CANCER
- Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer
- (2012) Y. Y. Zaytseva et al. CANCER RESEARCH
- Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration
- (2012) Yong Shu et al. Indian Journal of Pathology and Microbiology
- Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat
- (2012) HUI-QIONG HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17β-Estradiol in Cancer Cells and Cancer-associated Fibroblasts
- (2012) Maria Francesca Santolla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
- (2012) Carlos Turrado et al. JOURNAL OF MEDICINAL CHEMISTRY
- Blockade of Fatty Acid Synthase Triggers Significant Apoptosis in Mantle Cell Lymphoma
- (2012) Pascal Gelebart et al. PLoS One
- Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
- (2012) José Manuel Tirado-Vélez et al. PLoS One
- Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma
- (2012) A. P. Bhatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model
- (2012) H-W Chen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma
- (2012) Yu-Chien Kao et al. TUMOR BIOLOGY
- Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis
- (2012) ZHI LI LIU et al. Oncology Letters
- Therapeutic and Toxicologic Evaluation of Anti-Lipogenic Agents in Cancer Cells Compared with Non-Neoplastic Cells
- (2011) Perinkulam Ravi Deepa et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal
- (2011) Hui-Yen Chuang et al. BIOMEDICINE & PHARMACOTHERAPY
- Defining the Molecular Basis of Tumor Metabolism: a Continuing Challenge Since Warburg’s Discovery
- (2011) Ana Carolina Santos de Souza et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- mTOR links oncogenic signaling to tumor cell metabolism
- (2011) Jessica L. Yecies et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
- (2010) Jennifer F Barger et al. ENDOCRINE-RELATED CANCER
- Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
- (2010) Paul L. Nguyen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
- (2010) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- When Are "Positive" Clinical Trials in Oncology Truly Positive?
- (2010) A. Ocana et al. JNCI-Journal of the National Cancer Institute
- Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis
- (2010) Karina G Zecchin et al. LABORATORY INVESTIGATION
- ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas
- (2010) SD Silva et al. ORAL DISEASES
- Silencing of Ribosomal Protein S9 Elicits a Multitude of Cellular Responses Inhibiting the Growth of Cancer Cells Subsequent to p53 Activation
- (2010) Mikael S. Lindström et al. PLoS One
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
- (2010) A. J. Levine et al. SCIENCE
- Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
- (2010) Stefanie M. Ueda et al. Journal of Oncology
- Serum Fatty Acid Synthase as a Marker of Pancreatic Neoplasia
- (2009) K. Walter et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Novel roles for GAPDH in cell death and carcinogenesis
- (2009) A Colell et al. CELL DEATH AND DIFFERENTIATION
- Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities
- (2009) Peng-Yu Yang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of Fatty Acid Synthase by Orlistat Accelerates Gastric Tumor Cell Apoptosis in Culture and Increases Survival Rates in Gastric Tumor Bearing Mice In Vivo
- (2009) Shawn Dowling et al. LIPIDS
- Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer
- (2008) S. J. Yeung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model
- (2008) Marco A. Carvalho et al. INTERNATIONAL JOURNAL OF CANCER
- Human Glyceraldehyde-3-phosphate Dehydrogenase Plays a Direct Role in Reactivating Oxidized Forms of the DNA Repair Enzyme APE1
- (2008) Sonish Azam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Fatty-acid Synthase Induces Caspase-8-mediated Tumor Cell Apoptosis by Up-regulating DDIT4
- (2008) Lynn M. Knowles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ribosomal Protein S9 Is a Novel B23/NPM-binding Protein Required for Normal Cell Proliferation
- (2008) Mikael S. Lindström et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
- (2008) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Fatty Acid Synthase Over Expression is an Indicator of Tumor Aggressiveness and Poor Prognosis in Renal Cell Carcinoma
- (2008) Akio Horiguchi et al. JOURNAL OF UROLOGY
- Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells
- (2007) Shohei Kumagai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started